Bioxodes
PrivateLast Round
Series A
Extension
Dec 10, 2025
Total Funding Raised
$25.24M
Momentum Score
50 /100
Company Overview
Bioxodes is a clinical-stage biopharmaceutical company that develops therapies to treat thrombotic and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bioxodes Comps
Public and private peers based on sector, stage, and business model.
Bioxodes Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Dec 10, 2025 | ||||
| Series A Extension | Feb 12, 2025 | ||||
| Series A | Nov 21, 2023 | ||||
| Grant | Nov 21, 2023 | ||||
| Grant | Nov 1, 2013 | ||||
Seed | Nov 1, 2013 |
Bioxodes Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | Series A Extension |
| Newton Biocapital | Series A Extension |
| Life Sciences Research Partners | Seed, Series A Extension, Series A |
| European Regional Development Fund | Grant |
| Financière Spin-off Luxembourgeoise | Series A Extension, Seed, Series A |
| Sambrinvest | Series A Extension, Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
BIOX-101 for ICH is in dialogue with regulators for pivotal trial design.
- Apr 16, 2026
Monthly visitors increased 338% MoM.
Bioxodes Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bioxodes's valuation, stock price, and market status.
